Difficulty in Management of Advanced Pediatric Orbital Tumor
Downloads
Introduction: Tertiary care centers often manage pediatric orbital tumors, especially in advanced lesions and complex management. We report a case of a young boy with a malignant orbital tumor involving intracranial infiltration. Case presentation: A four-year-old boy had proptosis on the left eye for two months accompanied with blurred vision, pain, and oftenly bleeds with ipsilateral nasal congestion. There was no history of trauma, eye disorders, systemic diseases, or growth disorders. The physical examination showed stable vital signs, however a weak general condition and no enlarged regional lymph nodes. Visual acuity of the left eye was no light perception. There was a mass with protrusion of the left eye, swelling of the eyelid with an irregular surface, and a tendency to bleeds. The cornea was hazy with partly scarring, so we could not evaluate the posterior segment. MRI of the head presented a malignant soft tissue mass of the left orbital region with intracranial infiltration. The patient was given adjuvant chemotherapy; however, he could not survive due to systemic complications. Conclusions: The definitive diagnosis for the orbital tumor is obtained by histopathological examination. The investigation with CT scan or MRI imaging could be considered if not possible. However, since the definitive diagnosis still not assessed, the management can be affected. It is essential to have a definitive diagnosis to provide adequate treatment for the patients. Delayed and inadequate management can make malignant orbital tumors potentially life-threatening.
Lederman H, Rodrigues M, Tostes V, Caran E, Camargo M, Silva F, et al. Differential diagnosis of orbital tumors in children. Int J Radiol Radiat Ther 2017;3:252–6. https://doi.org/10.15406/ijrrt.2017.03.00068.
Eghtedari M, Farsiani AR, Bordbar MR. Congenital orbital rhabdomyosarcoma. Ocul Oncol Pathol 2018;4:165–9. https://doi.org/10.1159/000481533.
Yang W-J, Zhou Y-Y, Zhao F, Mei Z-M, Li S, Xiang Y. Orbital neuroblastoma metastasis: A case report and literature review. Medicine (Baltimore) 2019;98:e17038. https://doi.org/10.1097/md.00000 00000017038.
Rasool N, Odel JG, Kazim M. Optic pathway glioma of childhood. Curr Opin Ophthalmol 2017;28:289–95. https://doi.org/10.1097/icu.0000000000000370.
Farazdaghi MK, Katowitz WR, Avery RA. Current treatment of optic nerve gliomas. Curr Opin Ophthalmol 2019;30:356–63. https://doi.org/10.10 97/icu.0000000000000587.
Mombaerts I, Ramberg I, Coupland SE, Heegaard S. Diagnosis of orbital mass lesions: Clinical, radiological, and pathological recommendations. Surv Ophthalmol 2019;64:741–56. https://doi.org/10.1016/j.survophthal.2019.06.006.
Chawla B, Pujari A, Behera AK. Extraocular retinoblastoma: A neglected case. BMJ Case Rep 2017;2017:bcr2016218471. https://doi.org/10.1136/bcr-2016-218471.
Bradley JA, Kayton ML, Chi Y-Y, Hawkins DS, Tian J, Breneman J, et al. Treatment approach and outcomes in infants with localized rhabdomyosarcoma: A report from the soft tissue Sarcoma Committee of the Children's Oncology Group. Int J Radiat Oncol Biol Phys 2019;103:19–27. https://doi.org/10.1016/j.ijrobp.2018.08.017.
Meel R, Singh P. Pediatric orbital tumors-An overview. CLEVER Clin Exp Vis Eye Res 2018;1:38. https://doi.org/10.15713/ins.clever.8.
Thien HH, Kim Hoa NT, Duy PC, Carlos R-G, Son NH. Pediatric primary orbital rhabdomyosarcoma. J Pediatr Surg Case Reports 2020;59:101475. https://doi.org/https://doi.org/10.1016/j.epsc.2020.101475.
de Melo ACR, Lyra TC, Ribeiro ILA, da Paz AR, Bonan PRF, de Castro RD, et al. Embryonal rhabdomyosarcoma in the maxillary sinus with orbital involvement in a pediatric patient: Case report. World J Clin Cases 2017;5:440–5. https://doi.org/10.12998/wjcc.v5.i12.440.
Kobayashi K, Matsumoto F, Miyakita Y, Arikawa M, Omura G, Matsumura S, et al. Risk factors for delayed surgical recovery and massive bleeding in skull base surgery. Biomed Hub 2020;5:1–14. https://doi.org/10.1159/000507750.
Vision Science and Eye Health Journal by Universitas Airlangga is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
The journal allows the author to hold the copyright of the article without restrictions.
The journal allows the author(s) to retain publishing rights without restrictions.
The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution-Share-Alike (CC BY-SA).
The Creative Commons Attribution-Share-Alike (CC BY-SA) license allows re-distribution and re-use of a licensed work on the conditions that the creator is appropriately credited and that any derivative work is made available under "the same, similar or a compatible license”. Other than the conditions mentioned above, the editorial board is not responsible for copyright violations.